Literature DB >> 2852591

Dose-related carcinogenic effects of water-borne benzo[a]pyrene on livers of two small fish species.

W E Hawkins1, W W Walker, R M Overstreet, T F Lytle, J S Lytle.   

Abstract

Benzo[a]pyrene (BaP) administered by water-borne exposures caused dose-related carcinogenic effects in livers of two small fish species, the Japanese medaka (Oryzias latipes) and the guppy (Poecilia reticulata). Medaka and guppies each were given two 6-h exposures. The first exposure was conducted on 6- to 10-day-old specimens. The second exposure was given 7 days later. The tests incorporated five treatment groups: (1) control, (2) carrier (dimethylformamide) control, (3) low BaP dose (not detectable--4 ppb), (4) intermediate BaP dose (about 8-47 ppb BaP), and (5) high BaP dose (200-270 ppb). Following the high-dose exposure, hepatocellular lesions classified as foci of cellular alteration (altered foci), adenomas, and hepatocellular carcinomas occurred in both species. In medaka, the lesions appeared to develop sequentially with the appearance of altered foci followed by adenomas and then hepatocellular carcinomas. Most lesions in guppies, however, were classified as altered foci although a few adenomas occurred in the early (24-week) sample and hepatocellular carcinomas occurred in the late (52-week) sample. When total lesions were combined, medaka had an 11% incidence at 24 weeks after the initial exposure and 36% incidence at 36 weeks. In guppies, 8% had liver lesions at 24 weeks, 19% at 36 weeks, and 20% at 52 weeks. A single extrahepatic neoplasm, a capillary hemangioma in a gill filament, occurred in a medaka from the 36-week high-dose sample. The results suggest that the medaka and guppy are capable of metabolizing water-borne BaP to carcinogenic metabolites which initiate hepatic tumor development.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2852591     DOI: 10.1016/0147-6513(88)90052-8

Source DB:  PubMed          Journal:  Ecotoxicol Environ Saf        ISSN: 0147-6513            Impact factor:   6.291


  7 in total

1.  Expression of CYP1C1 and CYP1A in Fundulus heteroclitus during PAH-induced carcinogenesis.

Authors:  Lu Wang; Alvin C Camus; Wu Dong; Cammi Thornton; Kristine L Willett
Journal:  Aquat Toxicol       Date:  2010-06-19       Impact factor: 4.964

2.  Chronic Mycobacterium marinum infection acts as a tumor promoter in Japanese Medaka (Oryzias latipes).

Authors:  Gregory W Broussard; Michelle B Norris; Adam R Schwindt; John W Fournie; Richard N Winn; Michael L Kent; Don G Ennis
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2008-09-24       Impact factor: 3.228

3.  Contaminated sediments from tributaries of the Great Lakes: chemical characterization and carcinogenic effects in medaka (Oryzias latipes).

Authors:  D L Fabacher; J M Besser; C J Schmitt; J C Harshbarger; P H Peterman; J A Lebo
Journal:  Arch Environ Contam Toxicol       Date:  1991-07       Impact factor: 2.804

4.  Comprehensive profiling of zebrafish hepatic proximal promoter CpG island methylation and its modification during chemical carcinogenesis.

Authors:  Leda Mirbahai; Timothy D Williams; Huiqing Zhan; Zhiyuan Gong; J Kevin Chipman
Journal:  BMC Genomics       Date:  2011-01-04       Impact factor: 3.969

Review 5.  Fish models for environmental carcinogenesis: the rainbow trout.

Authors:  G S Bailey; D E Williams; J D Hendricks
Journal:  Environ Health Perspect       Date:  1996-03       Impact factor: 9.031

6.  Bioavailability and biotransformation of benzo(a)pyrene in an isolated perfused In situ catfish intestinal preparation.

Authors:  K M Kleinow; M O James; Z Tong; C S Venugopalan
Journal:  Environ Health Perspect       Date:  1998-03       Impact factor: 9.031

7.  Health of white sucker within the St. Louis River area of concern associated with habitat usage as assessed using stable isotopes.

Authors:  V S Blazer; J Hoffman; H L Walsh; R P Braham; C Hahn; P Collins; Z Jorgenson; T Ledder
Journal:  Ecotoxicology       Date:  2013-12-27       Impact factor: 2.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.